Clinical significance of prognostic and predictive markers in colorectal cancer
- 1 April 2002
- journal article
- review article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 2 (4), 209-216
- https://doi.org/10.1038/sj.tpj.6500124
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Ki‐ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancerThe Journal of Pathology, 2001
- Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon CancerNew England Journal of Medicine, 2001
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Deleted in Colorectal Cancer (DCC) Encodes a Netrin ReceptorCell, 1996
- The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus ImmunohistochemistryJNCI Journal of the National Cancer Institute, 1996
- Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinomaGenes, Chromosomes and Cancer, 1994
- Severe 5-Fluorouracil Toxicity in a Patient with Decreased Dihydropyrimidine Dehydrogenase ActivityCancer Investigation, 1993
- p53, guardian of the genomeNature, 1992
- A genetic model for colorectal tumorigenesisCell, 1990